Document is current
Any future updates will be listed below
-
Authors
Yin, Qian
Luo, Wei https://orcid.org/0000-0003-2826-1723
Mallajosyula, Vamsee https://orcid.org/0000-0002-0658-3652
Bo, Yang
Guo, Jing https://orcid.org/0000-0002-6616-2585
Xie, Jinghang https://orcid.org/0000-0003-0894-5765
Sun, Meng
Verma, Rohit
Li, Chunfeng
Constantz, Christian M.
Wagar, Lisa E. https://orcid.org/0000-0001-5980-3586
Li, Jing
Sola, Elsa
Gupta, Neha
Wang, Chunlin
Kask, Oliver
Chen, Xin
Yuan, Xue
Wu, Nicholas C. https://orcid.org/0000-0002-9078-6697
Rao, Jianghong https://orcid.org/0000-0002-5143-9529
Chien, Yueh-hsiu
Cheng, Jianjun https://orcid.org/0000-0003-2561-9291
Pulendran, Bali https://orcid.org/0000-0001-6517-4333
Davis, Mark M. https://orcid.org/0000-0001-6868-657X
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute
Bill and Melinda Gates Foundation (INV003875)
- License Information
-
More Information
Article History
Received: 24 September 2021
Accepted: 12 December 2022
First Online: 30 January 2023
Competing interests
: Q.Y., M.M.D., W.L. and B.P. are inventors on a patent application that describes the use of this nanoparticle for vaccine adjuvant. The remaining authors declare no competing interests.
